|
|
|
|
| As the final step before products reach patients, fill and finish are critical to drug development. On top of quality standards, diverse manufacturing requirements, and evolving regulatory landscapes, the industry is experiencing added pressure from the growth of low-volume therapeutics and multi-product facilities – all resulting in a rising need for flexible manufacturing. Take control of your final formulation and filling by choosing a supplier who combines flexible single-use technologies, trusted regulatory expertise, and industry-leading support. |
|
|
FOCUS ON DOWNSTREAM MANUFACTURING |
|
|
|
A conversation with Juan-Carlos Rosario, Eli Lilly and Company | Serotype-specific resins don't scale gracefully. One team at Eli Lilly and Company is exploring an alternative that skips affinity resins altogether. | |
|
|
|
| Development Of Improved Chromatographic Methods | Poster | By Paul Rainville, Brianna Clements, Adam Bengtson, and Norris Wong, Waters Corporation | Explore the evolving role of GLP-1 agonists in weight management and diabetes care, and discover the urgent need for advanced chromatography methods to ensure pharmaceutical quality and safety. |
|
|
|
|
| CHT Chromatography Media: 5 Essential Facts | Webinar | Bio-Rad Laboratories, Inc. | CHT provides exceptional removal of impurities when other chromatography resins fall short to provide the same level of purity. Explore the essential facts and benefits of this chromatography technology. |
|
|
DOWNSTREAM MANUFACTURING SOLUTIONS |
|
|
|
|
|
|
|
| Webinar: Streamlining Vaccine Purification: Techniques for Modern Modalities | Advances in vaccine development demand faster, more efficient processes. This Thermo Fisher Scientific webinar explores chromatography purification tools that accelerate downstream development for diverse vaccine modalities, including mRNA, viral vectors, recombinant proteins, and VLPs. Through case studies on HPV, Malaria, and COVID-19, attendees will learn how affinity and ion exchange resins enable high-purity, high-yield purification from lab to large-scale production. Click here to learn more. |
|
|
|
|
By Better Biopharma | Lumen Bioscience is putting the farm in biopharma — literally! In this episode of Better Biopharma, Lumen's EVP of production and development, Craig Behnke, Ph.D., explains the company's chlorophyll-powered approach to bioprocessing using photosynthetic cyanobacteria. | |
|
|
|
| Key Metrics In Antibody Drug Development | Webinar | TA Instruments | Learn about key techniques, such as DSC and Rheology, to evaluate thermal stability and viscosity in antibody drug development. Gain insights to enhance candidate selection, formulation, and delivery. |
|
|
|
|
|
|
| Webinar: Filtration unfiltered: Technology to meet new bioprocessing challenges | Join Cytiva experts as they reveal how to overcome filtration challenges in today’s evolving biopharma landscape. Discover how process intensification drives efficiency, explore strategies for managing diverse drug modalities, and gain insights into key regulatory considerations—including PUPSIT and PFAS. Don’t miss this opportunity to learn how smarter filtration solutions can boost productivity and support sustainable bioprocessing. Click here to learn more. |
|
|
|
|
| Connect With Bioprocess Online: |
|
|
|
